A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts von Garcia-Manero, G, Sekeres, M A, Egyed, M, Breccia, M, Graux, C, Cavenagh, J D, Salman, H, Illes, A, Fenaux, P, DeAngelo, D J, Stauder, R, Yee, K, Zhu, N, Lee, J-H, Valcarcel, D, MacWhannell, A, Borbenyi, Z, Gazi, L, Acharyya, S, Ide, S, Marker, M, Ottmann, O G

Volltext

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial) von Chanan-Khan, A, Egyed, M, Robak, T, Martinelli de Oliveira, F A, Echeveste, M A, Dolan, S, Desjardins, P, Blonski, J Z, Mei, J, Golany, N, Zhang, J, Gribben, J G

Volltext

Increased Lipocalin 2 level may have important role in thrombotic events in patients with polycythemia vera and essential thrombocythemia von Rajnics, P, Kellner, Á, Karádi, É, Moizs, M, Bödör, Cs, Király, P.A, Marosvári, D, Andrikovics, H, Egyed, M

Volltext

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES von Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva‐Kyuchukova, L., Egyed, M., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Empson, V., Krejcy, K., Hasselbalch, H., Kralovics, R., Kiladjian, J.‐J.

Volltext

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS‐3 TRIAL... von Zinzani, P. L., Özcan, M., Sapunarova, K., Jurczak, W., Hamed, A., Bouabdallah, K., Saydam, G., Geissler, K., Szomor, Á., Lazaroiu, M., Salar, A., Tempescul, A., Nalcaci, M., Gercheva, L., Egyed, M., Panayiotidis, P., Mongay Soler, L., Cao, A., Phelps, C., H Childs, B., J Matasar, M.

Volltext

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN von Sharman, J. P., Egyed, M., Jurczak, W., Skarbnik, A., Patel, K., Flinn, I. W., Kamdar, M., Munir, T., Walewska, R., Fogliatto, L. M., Herishanu, Y., Banerji, V., Follows, G., Walker, P., Karlsson, K., Ghia, P., Janssens, A., Cymbalista, F., Ferrant, E., Wierda, W. G., Munugalavadla, V., Yu, T., Wang, M. H., Woyach, J. A.

Volltext

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM] von Vannucchi, A., Mesa, R., Gerds, A., Al‐Ali, H. K., Lavie, D., Kuykendall, A., Grosicki, S., Iurlo, A., Goh, Y. T., Lazaroiu, M., Egyed, M., Fox, M. L., McLornan, D., Perkins, A., Yoon, S.‐S., Gupta, V., Kiladjian, J.‐J., Donahue, R., Kawashima, J., Verstovsek, S.

Volltext

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR von Verstovsek, S., Vannucchi, A., Gerds, A., Al-Ali, H. K., Lavie, D., Kuykendall, A., Grosicki, S., Iurlo, A., Goh, Y. T., Lazaroiu, M., Egyed, M., Fox, M. L., McLornan, D., Perkins, A., Yoon, S.-S., Gupta, V., Kiladjian, J.-J., Donahue, R., Kawashima, J., Mesa, R.

Volltext

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG‐TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN‐LABEL EXTENSION von Röth, A., Egyed, M., Ichikawa, S., Ito, Y., Kim, J. S., Nagy, Z., Obara, N., Panse, J., Schrezenmeier, H., Sica, S., Soret, J., Usuki, K., Yoon, S.‐S., Benkali, K., Buri, M., Lundberg, P., Patel, H., Shinomiya, K., Sreckovic, S., Nishimura, J.‐I.

Volltext

P615: BCL2 RESISTANCE MUTATIONS IN A REAL‐WORLD COHORT OF PATIENTS WITH VENETOCLAX‐TREATED CHRONIC LYMPHOCYTIC LEUKAEMIA von Kotmayer, L., László, T., Kiss, R., Hegyi, L. L., Mikala, G., Farkas, P., Balogh, A., Masszi, T., Demeter, J., Weisinger, J., Alizadeh, H., Gergely, L., Sulák, A., Egyed, M., Plander, M., Pettendi, P., Lévai, D., Schneider, T., Pauker, Z., Masszi, A., Szász, R., Bödör, C., Alpár, D.

Volltext

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 tr... von Sharman, J. P., Egyed, M., Jurczak, W.

Volltext

A PHASE 2B STUDY OF SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) von Kalakonda, N., Cavallo, F., Follows, G., Goy, A., Vermaat, J., Casasnovas, O., Lavee, O., Maerevoet, M., Zijlstra, J., Bakshi, S., Bouabdallah, R., Choquet, S., Gurion, R., Hill, B., Jaeger, U., Sancho, J., Schuster, M., Thieblemont, C., De la Cruz, F., Egyed, M., Mishra, S., Offner, F., Vassilakopoulos, T., Warzocha, K., Oluyadi, A., McCarthy, D., Ma, X., Corona, K., Shah, J., Van Den Neste, E., Canales, M.

Volltext

JAK2 46 1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia von Andrikovics, H, Nahajevszky, S, Koszarska, M, Meggyesi, N, Bors, A, Halm, G, Lueff, S, Lovas, N, Matrai, Z, Csomor, J, Rasonyi, R, Egyed, M, Varkonyi, J, Mikala, G, Sipos, A, Kozma, A, Adam, E, Fekete, S, Masszi, T, Tordai, A

Volltext

PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION IN UNTREATED DLBCL: RESULTS FROM THE PHASE III GOYA STUDY von Sehn, L.H., Oestergaard, M.Z., Trněný, M., Bosi, A., Egyed, M., Illes, A., Nakamae, H., Opat, S., Topp, M., Zaja, F., Fingerle‐Rowson, G., Lei, G., Nielsen, T., Punnoose, E.A., Rahman, M., Ray, J., Zhang, L., Martelli, M., Vitolo, U.

Volltext

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax von Kotmayer, Lili, László, Tamás, Mikala, Gábor, Kiss, Richárd, Lévay, Luca, Hegyi, Lajos László, Gróf, Stefánia, Nagy, Tibor, Barna, Gábor, Farkas, Péter, Weisinger, Júlia, Nagy, Zsolt, Balogh, Alexandra, Masszi, Tamás, Demeter, Judit, Sulák, Adrienn, Kohl, Zoltán, Alizadeh, Hussain, Egyed, Miklós, Pettendi, Piroska, Gergely, Lajos, Plander, Márk, Pauker, Zsolt, Masszi, András, Matolcsy, András, Szász, Róbert, Bödör, Csaba, Alpár, Donát

Volltext

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations von Andrikovics, Hajnalka, Krahling, Tunde, Balassa, Katalin, Halm, Gabriella, Bors, Andras, Koszarska, Magdalena, Batai, Arpad, Dolgos, Janos, Csomor, Judit, Egyed, Miklos, Sipos, Andrea, Remenyi, Peter, Tordai, Attila, Masszi, Tamas

Volltext

Successful treatment of a primary uterine B-cell lymphoma with rituximab-CHOP immunochemotherapy von Egyed, M, Kollar, B, Prievara, F.T, Viski, A, Bajzik, G, Pajor, L, Torday, L

Volltext

Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy von Bödör, Csaba, Kotmayer, Lili, László, Tamás, Takács, Ferenc, Barna, Gábor, Kiss, Richárd, Sebestyén, Endre, Nagy, Tibor, Hegyi, Lajos László, Mikala, Gábor, Fekete, Sándor, Farkas, Péter, Balogh, Alexandra, Masszi, Tamás, Demeter, Judit, Weisinger, Júlia, Alizadeh, Hussain, Kajtár, Béla, Kohl, Zoltán, Szász, Róbert, Gergely, Lajos, Gurbity Pálfi, Timea, Sulák, Adrienn, Kollár, Balázs, Egyed, Miklós, Plander, Márk, Rejtő, László, Szerafin, László, Ilonczai, Péter, Tamáska, Péter, Pettendi, Piroska, Lévai, Dóra, Schneider, Tamás, Sebestyén, Anna, Csermely, Péter, Matolcsy, András, Mátrai, Zoltán, Alpár, Donát

Volltext

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma von LUDWIG, Heinz, ADAM, Zdenek, HINKE, Axel, ZOJER, Niklas, TOTHOVA, Elena, HAJEK, Roman, LABAR, Boris, EGYED, Miklós, SPICKA, Ivan, GISSLINGER, Heinz, DRACH, Johannes, KUHN, Ingrid

Volltext

P051 Pulmonary embolism in a Hungarian Teaching Hospital von Egyed, M, Zádori, P, Horváth, A, Horváth, G

Volltext